4.7 Review

Rethinking ovarian cancer: recommendations for improving outcomes

期刊

NATURE REVIEWS CANCER
卷 11, 期 10, 页码 719-725

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrc3144

关键词

-

类别

资金

  1. Cancer Research UK [15601] Funding Source: researchfish
  2. Medical Research Council [G0601891, G0501974] Funding Source: researchfish
  3. MRC [G0501974, G0601891] Funding Source: UKRI
  4. Cancer Research UK [15601] Funding Source: Medline
  5. Medical Research Council [G0601891, G0501974] Funding Source: Medline
  6. NCI NIH HHS [R01 CA085289, P50 CA105009, R01 CA111882, P50 CA098258, U54 CA151668, U01 CA151461, P50 CA083639, U01 CA152990, CA85289, P30 CA016672, P50 CA83639, CA109298] Funding Source: Medline
  7. NIGMS NIH HHS [RC2GM092599] Funding Source: Medline

向作者/读者索取更多资源

There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据